Hap Trading, LLC Astrazeneca PLC Call Options Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $6.92 Million - $7.85 Million	109,600 Added 782.86%	123,600 $220,000
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $162,630 - $211,320	-3,000 Reduced 17.65%	14,000 $47,000
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $355,234 - $909,525	6,700 Added 65.05%	17,000 $9,000
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $5.69 Million - $6.83 Million	-96,000 Reduced 90.31%	10,300 $53,000
Q1 2022 May 12, 2022	BUY	$55.72 - $67.12 $3.74 Million - $4.5 Million	67,100 Added 171.17%	106,300 $370,000
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $664,446 - $785,109	-12,300 Reduced 23.88%	39,200 $78,000
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $466,704 - $510,636	8,400 Added 19.49%	51,500 $152,000
Q2 2021 Aug 11, 2021	SELL	$48.42 - $60.18 $1.14 Million - $1.41 Million	-23,500 Reduced 35.29%	43,100 $215,000
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $2.95 Million - $3.41 Million	-62,600 Reduced 48.45%	66,600 $117,000
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $824,840 - $986,340	17,000 Added 15.15%	129,200 $132,000
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $2.79 Million - $3.21 Million	52,500 Added 87.94%	112,200 $127,000
Q2 2020 Aug 10, 2020	BUY	$43.1 - $55.31 $1.99 Million - $2.56 Million	46,200 Added 342.22%	59,700 $178,000
Q1 2020 May 08, 2020	SELL	$37.79 - $51.33 $634,872 - $862,344	-16,800 Reduced 55.45%	13,500 $28,000
Q4 2019 Feb 11, 2020	BUY	$42.46 - $50.46 $178,332 - $211,932	4,200 Added 16.09%	30,300 $250,000
Q3 2019 Nov 12, 2019	BUY	$40.12 - $45.47 $481,439 - $545,640	12,000 Added 85.11%	26,100 $149,000
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $525,648 - $587,688	14,100 New	14,100 $16,000
Q3 2018 Nov 09, 2018	SELL	$34.76 - $39.72 $389,312 - $444,864	-11,200 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$34.55 - $37.05 $176,205 - $188,955	-5,100 Reduced 31.29%	11,200 $20,000
Q1 2018 May 11, 2018	SELL	$32.97 - $36.63 $2.89 Million - $3.22 Million	-87,800 Reduced 84.34%	16,300 $19,000
Q4 2017 Feb 09, 2018	SELL	$32.09 - $34.78 $64,180 - $69,560	-2,000 Reduced 1.89%	104,100 $51,000
Q3 2017 Nov 08, 2017	BUY	$28.96 - $34.0 $3.07 Million - $3.61 Million	106,100	106,100 $116,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.17 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.78 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.47 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.44 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.27 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account